Methamphetamine-Induced Brain Injury and Alcohol Drinking

dc.contributor.authorBlaker, Amanda L.
dc.contributor.authorYamamoto, Bryan K.
dc.contributor.departmentPharmacology and Toxicology, School of Medicineen_US
dc.date.accessioned2019-07-26T19:42:35Z
dc.date.available2019-07-26T19:42:35Z
dc.date.issued2018-03
dc.description.abstractA majority of methamphetamine (Meth) abusers also abuse alcohol but the neurochemical consequences of this co-abuse are unknown. Individually, alcohol and Meth cause inflammation and long-term alterations in dopamine and serotonin signaling within the brain. Experiments were conducted to identify if serial exposure to alcohol and Meth has neurochemical consequences that are greater than after either drug alone. Male Sprague Dawley rats voluntarily drank 10% ethanol (EtOH) every other day for 4 weeks and were then exposed to a binge injection regimen of Meth (10 mg/kg injected every 2 h, for a total of 4 injections). EtOH drinking and preference increased over the 4 weeks and caused inflammation evidenced by increases in serum and brain lipopolysaccharide (LPS) and brain cyclooxygenase-2 (COX-2) 24 h after the last day of drinking. Meth alone depleted dopamine and serotonin in the striatum, as well as serotonin in the prefrontal cortex when measured 1 week later. In contrast, EtOH drinking alone did not affect dopamine and serotonin content in the striatum and prefrontal cortex, but prior EtOH drinking followed by injections of Meth enhanced Meth-induced depletions of dopamine, serotonin, as well as dopamine and serotonin transporter immunoreactivities in a manner that was correlated with the degree of EtOH consumption. Cyclooxygenase inhibition by ketoprofen during EtOH drinking blocked the increases in LPS and COX-2 and the enhanced decreases in dopamine and serotonin produced by Meth. Therefore, prior EtOH drinking causes an increase in inflammatory mediators that mediate a synergistic interaction with Meth to cause an enhanced neurotoxicity.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationBlaker, A. L., & Yamamoto, B. K. (2018). Methamphetamine-Induced Brain Injury and Alcohol Drinking. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 13(1), 53–63. doi:10.1007/s11481-017-9764-3en_US
dc.identifier.urihttps://hdl.handle.net/1805/19967
dc.language.isoen_USen_US
dc.publisherSpringeren_US
dc.relation.isversionof10.1007/s11481-017-9764-3en_US
dc.relation.journalJournal of Neuroimmune Pharmacologyen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectMethamphetamineen_US
dc.subjectAlcoholen_US
dc.subjectCyclooxygenase-2en_US
dc.subjectLipopolysaccharideen_US
dc.subjectMonoaminesen_US
dc.titleMethamphetamine-Induced Brain Injury and Alcohol Drinkingen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms903088.pdf
Size:
1.39 MB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: